M3 FGDSRDRS Flashcards
Three phases of Cell growth
Hyperplasia
Hyperplasia + Hypertrophy
Hypertrophy
Hyperplasia + Hypertrophy. What weeks AOG?
Phase of cell growth at 17-32 weeks AOG.
Determinants of hyperplasia
Fetal genome
Determinants of hypertrophy EXCEPT A. Environmental b. Nutritional c. Hormonal d. Fetal Genome
D
IUGR is best diagnosed
a. first 16 weeks
b. 17-32 weeks
c. after 32 weeks
d. Any time
C
True about symmetrical IUGR EXCEPT
a. Reduced head and body size
b. usually occurs due to placental insufficiency from hypertension
c. least likely due to infection
d. Results in decreased cell number and size
B and C
True about asymmetrical IUGR
a. reduced head and body size
b. usually occurs in infections
c. due to late pregnancy insult
d. decreased cell number and size
C.
A. reduced body size
B, C late pregnancy insult (placental insufficiency from hypertension)
D. Decreased cell size only
The following are risk factors for IUGR EXCEPT
a. constitutionally small mother
b. poor maternal nutrition
c. social deprivation
d. CMV
e. NOTA
E;
The ff are risk factors for IUGR EXCEPT
a. Chorioangioma
b. Preeclampsia
c. APS
d. NOTA
D
Most common abnormal sonographic finding in IUGR
Abdominal Circumference
Prophylaxis in early gestation is done with what medication?
Low dose aspirin (effectively only in 10% cases)
What is the management for IUGR >/= 34 weeks with reassuring FHR
Vaginal delivery
What is the management for IUGR >/= 34 weeks with nonreassuring FHR
CS
What is the management for IUGR <34 weeks
Observation and monitoring until fetal maturity is attained Qualifications: -normal fetus -normal AFI -normal fetal surveillance -fetal growth continues
Definition of macrosomia
fetus weighing >4,000 (GDM) - >4,500 (nonGDM)
or 4250 ba? verify